Literature DB >> 19288085

Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.

Michael B Gatch1, Margaret A Rutledge, Theresa Carbonaro, Michael J Forster.   

Abstract

RATIONALE: There has been increased recreational use of dimethyltryptamine (DMT), but little is known of its discriminative stimulus effects.
OBJECTIVES: The present study assessed the similarity of the discriminative stimulus effects of DMT to other types of hallucinogens and to psychostimulants.
METHODS: Rats were trained to discriminate DMT from saline. To test the similarity of DMT to known hallucinogens, the ability of (+)-lysergic acid diethylamide (LSD), (-)-2,5-dimethoxy-4-methylamphetamine (DOM), (+)-methamphetamine, or (+/-)3,4-methylenedioxymethyl amphetamine (MDMA) to substitute in DMT-trained rats was tested. The ability of DMT to substitute in rats trained to discriminate each of these compounds was also tested. To assess the degree of similarity in discriminative stimulus effects, each of the compounds was tested for substitution in all of the other training groups.
RESULTS: LSD, DOM, and MDMA all fully substituted in DMT-trained rats, whereas DMT fully substituted only in DOM-trained rats. Full cross-substitution occurred between DMT and DOM, LSD and DOM, and (+)-methamphetamine and MDMA. MDMA fully substituted for (+)-methamphetamine, DOM, and DMT, but only partially for LSD. In MDMA-trained rats, LSD and (+)-methamphetamine fully substituted, whereas DMT and DOM did not fully substitute. No cross-substitution was evident between (+)-methamphetamine and DMT, LSD, or DOM.
CONCLUSIONS: DMT produces discriminative stimulus effects most similar to those of DOM, with some similarity to the discriminative stimulus effects of LSD and MDMA. Like DOM and LSD, DMT seems to produce predominately hallucinogenic-like discriminative stimulus effects and minimal psychostimulant effects, in contrast to MDMA which produced hallucinogen- and psychostimulant-like effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288085      PMCID: PMC2865430          DOI: 10.1007/s00213-009-1501-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  52 in total

1.  Tolerance to behavioral effects of N, N-dimethyltryptamine in mice.

Authors:  S G Cooper; S R Schiff; W H Bridger
Journal:  Biol Psychiatry       Date:  1981-09       Impact factor: 13.382

2.  Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.

Authors:  R A Lyon; M Titeler; M R Seggel; R A Glennon
Journal:  Eur J Pharmacol       Date:  1988-01-19       Impact factor: 4.432

3.  MDMA-like stimulus effects of hallucinogens in male Fawn-Hooded rats.

Authors:  M D Schechter
Journal:  Pharmacol Biochem Behav       Date:  1998-02       Impact factor: 3.533

4.  Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis.

Authors:  B Sadzot; J M Baraban; R A Glennon; R A Lyon; S Leonhardt; C R Jan; M Titeler
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Authors:  R J Strassman; C R Qualls; E H Uhlenhuth; R Kellner
Journal:  Arch Gen Psychiatry       Date:  1994-02

6.  Effects of DOM and DMT in a proposed animal model of hallucinogenic activity.

Authors:  L M Adams; M A Geyer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1985       Impact factor: 5.067

7.  Interactions of partial LSD analogs with behavioral disrupting effects of LSD and DMT in the rat.

Authors:  B Kovacic; L J Wang Lu; D Ruffing; E F Domino
Journal:  Eur J Pharmacol       Date:  1978-01-01       Impact factor: 4.432

8.  Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.

Authors:  R L Smith; H Canton; R J Barrett; E Sanders-Bush
Journal:  Pharmacol Biochem Behav       Date:  1998-11       Impact factor: 3.533

9.  Effects of N,N-dimethyltryptamine on behavioural habituation in the rat.

Authors:  S E File
Journal:  Pharmacol Biochem Behav       Date:  1977-02       Impact factor: 3.533

10.  Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.

Authors:  R J Strassman; C R Qualls; L M Berg
Journal:  Biol Psychiatry       Date:  1996-05-01       Impact factor: 13.382

View more
  19 in total

1.  The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.

Authors:  Theresa M Carbonaro; Amy J Eshleman; Michael J Forster; Kejun Cheng; Kenner C Rice; Michael B Gatch
Journal:  Psychopharmacology (Berl)       Date:  2014-07-03       Impact factor: 4.530

2.  Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice.

Authors:  Mario de la Fuente Revenga; Urjita H Shah; Nima Nassehi; Alaina M Jaster; Prithvi Hemanth; Salvador Sierra; Malgorzata Dukat; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2021-01-05       Impact factor: 4.418

3.  Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

4.  Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.

Authors:  Clinton E Canal
Journal:  Handb Exp Pharmacol       Date:  2018

5.  Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression.

Authors:  Lindsay P Cameron; Charlie J Benson; Lee E Dunlap; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-04-24       Impact factor: 4.418

6.  Discriminative stimulus effects of N,N-diisopropyltryptamine.

Authors:  Theresa M Carbonaro; Michael J Forster; Michael B Gatch
Journal:  Psychopharmacology (Berl)       Date:  2012-10-16       Impact factor: 4.530

7.  The HIV antiretroviral drug efavirenz has LSD-like properties.

Authors:  Michael B Gatch; Alexey Kozlenkov; Ren-Qi Huang; Wenjuan Yang; Jacques D Nguyen; Javier González-Maeso; Kenner C Rice; Charles P France; Glenn H Dillon; Michael J Forster; John A Schetz
Journal:  Neuropsychopharmacology       Date:  2013-05-24       Impact factor: 7.853

Review 8.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

9.  Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Behav Pharmacol       Date:  2016-09       Impact factor: 2.293

10.  Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.

Authors:  Amy J Eshleman; Michael J Forster; Katherine M Wolfrum; Robert A Johnson; Aaron Janowsky; Michael B Gatch
Journal:  Psychopharmacology (Berl)       Date:  2013-10-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.